(Q45419995)

English

Effects of discontinuing stavudine or protease inhibitor therapy on human immunodeficiency virus-related fat redistribution evaluated by dual-energy x-ray absorptiometry

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Effects of discontinuing stavudine or protease inhibitor therapy on human immunodeficiency virus-related fat redistribution evaluated by dual-energy x-ray absorptiometry (English)

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

1 reference

based on heuristic

inferred from title

author name string

Neda Tavassoli

1

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Haleh Bagheri

2

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Agnes Sommet

3

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Cyrille Delpierre

4

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Fabrice Marion-Latard

5

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Patrice Massip

6

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Christian Aquilina

7

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Eric Bonnet

8

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Martine Obadia

9

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Eric Labau

10

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Jean Louis Montastruc

11

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Jacques Bernard

12

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

language of work or name

0 references

publication date

1 February 2006

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Pharmacotherapy

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

26

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

154-161

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.2.154

21 January 2018

A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.2.154

21 January 2018

The HIV protease inhibitor indinavir impairs sterol regulatory element-binding protein-1 intranuclear localization, inhibits preadipocyte differentiation, and induces insulin resistance

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.2.154

21 January 2018

Suppression of preadipocyte differentiation and promotion of adipocyte death by HIV protease inhibitors

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.2.154

21 January 2018

Mitochondrial toxicity induced by nucleoside-analogue reverse-transcriptase inhibitors is a key factor in the pathogenesis of antiretroviral-therapy-related lipodystrophy

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.2.154

21 January 2018

Lipodystrophy, insulin resistance, diabetes mellitus, dyslipidemia, and cardiovascular disease in human immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.2.154

21 January 2018

Factors related to lipodystrophy and metabolic alterations in patients with human immunodeficiency virus infection receiving highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.2.154

21 January 2018

A syndrome of peripheral fat wasting (lipodystrophy) in patients receiving long-term nucleoside analogue therapy.

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.2.154

21 January 2018

A syndrome of lipoatrophy, lactic acidaemia and liver dysfunction associated with HIV nucleoside analogue therapy: contribution to protease inhibitor-related lipodystrophy syndrome.

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.2.154

21 January 2018

HIV protease inhibitor substitution in patients with lipodystrophy: a randomized, controlled, open-label, multicentre study

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.2.154

21 January 2018

Abacavir substitution for nucleoside analogs in patients with HIV lipoatrophy: a randomized trial

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.2.154

21 January 2018

Thymidine analogue withdrawal for lipoatrophic patients on protease-sparing therapy improves lipoatrophy but compromises antiviral control: the PIILR extension study

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.2.154

21 January 2018

Reversibility of lipoatrophy in HIV-infected patients 2 years after switching from a thymidine analogue to abacavir: the MITOX Extension Study

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.2.154

21 January 2018

Total body composition by DXA of 241 HIV-negative men and 162 HIV-infected men: proposal of reference values for defining lipodystrophy

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.2.154

21 January 2018

A randomized trial of simplified maintenance therapy with abacavir, lamivudine, and zidovudine in human immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.2.154

21 January 2018

Identifiers

10.1592/PHCO.26.2.154

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45419995&oldid=2076899300"